The number of people with susceptibility test result for rifampicin in Mali
Mali: The number of people with susceptibility test result for rifampicin was 1,234 in 2021. ◆ Volatile
Latest (2021)
1,234
Change on year
down 48.8%
World rank
61st
of 155 countries
All-time high
2,412
in 2020
All-time low
12
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Mali, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Mali is 1,234, measured in 2021.
Compared with earlier readings it is down 48.8% on the previous year and up 300.6% over five years.
Mali ranks 61st of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Mali, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 308 | — |
| 2018 | 103 | -66.6% |
| 2019 | 12 | -88.3% |
| 2020 | 2,412 | +20000.0% |
| 2021 | 1,234 | -48.8% |
Mali compared with similar countries
- Mali's 1,234 is below the median for low income countries, which is 1,934, 64% of the median. (15 countries reporting)
- Mali's 1,234 is below the median for Sub-Saharan Africa, which is 2,015, 61% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 141 | 12 | 308 | 3 |
| 2020s | 1,823 | 1,234 | 2,412 | 2 |
Countries ranked near Mali
More health data for Mali
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.18 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 878 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24,194 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 2.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0853 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.19 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Mali?
- The number of people with susceptibility test result for rifampicin in Mali was 1,234 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Mali?
- The highest recorded value was 2,412 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Mali?
- The lowest recorded value was 12 in 2019.
- How does Mali rank for the number of people with susceptibility test result for rifampicin?
- Mali ranks 61st out of 155 countries with data for 2021.
- Where does this Mali data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).